Invention Grant
- Patent Title: Functionalized Exendin-4 derivatives
-
Application No.: US15486054Application Date: 2017-04-12
-
Publication No.: US10253079B2Publication Date: 2019-04-09
- Inventor: Torsten Haack , Michael Wagner , Bernd Henkel , Siegfried Stengelin , Andreas Evers , Martin Lorenz , Katrin Lorenz
- Applicant: SANOFI
- Applicant Address: FR Paris
- Assignee: SANOFI
- Current Assignee: SANOFI
- Current Assignee Address: FR Paris
- Agency: Lathrop Gage LLP
- Agent James H. Velema, Esq.
- Priority: EP12306647 20121221
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K45/00 ; A61P25/00 ; A61P3/04 ; A61P3/06 ; A61P3/10 ; A61P9/00 ; A61P9/10 ; A61P9/12 ; C07K14/575 ; C07K14/605 ; A61K38/26 ; A61K45/06 ; A61K38/28 ; A61K38/22 ; A61K9/00

Abstract:
The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
Public/Granted literature
- US20170216406A1 FUNCTIONALIZED EXENDIN-4 DERIVATIVES Public/Granted day:2017-08-03
Information query
IPC分类: